Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

Director Baynes Roy D. exercised 4,500 shares at a strike of $21.38 and sold $225,000 worth of shares (4,500 units at $50.00) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.

Director Baynes Roy D. exercised 4,500 shares at a strike of $21.38 and sold $225,000 worth of shares (4,500 units at $50.00) as part of a pre-agreed trading plan (SEC Form 4) | Quantisnow